Mkts

BioCryst Pharmaceuticals, Inc.

NASDAQ: BCRX
$7.69+0.06 (+0.79%)
As of Nov 6, 4:00 PM ET

Key statistics

Day range
7.387.83
52-week range
6.2311.22
Today
Open7.81
Previous close7.69
Volume4.40M
Valuation
Market cap1.98B
P/E ratio—
EPS (TTM)-1.50
Income & risk
Dividend / yield—
Beta0.53
Avg volume4.62M
Discussion

BCRX News

Stories mentioning BCRX from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue
Cost of Goods Sold5,3779,5222,1872,7984,5686,0943,2111,699
Gross Profit(5,377)(9,522)(2,187)(2,798)(4,568)(6,094)(3,211)(1,699)
Operating Expenses
Research & Development60,31940,86744,60343,38637,27049,44141,08137,623
Sales General & Admin94,55495,78183,01487,38382,46980,50765,10161,249
Total Operating Expenses
Operating Income (Loss)(701,598)260,38529,59129,78621,227(4,508)7,6928,761
Interest Income
Interest Expense24,733
Other Expense(1,462)0.00
Pretax Income(720,808)248,01712,1306,486758.00(25,991)(13,447)(12,502)
Tax Provision1,0042,172(769.00)1,401726.00804.00586.00172.00
Net Income (Loss)(721,812)245,84512,8995,08532.00(26,795)(14,033)(12,674)
Earnings Per Share (Basic)(2.98)1.170.060.020.00(0.13)(0.07)(0.06)
Earnings Per Share (Diluted)(2.98)1.120.060.020.00(0.13)(0.07)(0.06)
Weighted Average Shares Outstanding (Basic)242,258209,893210,176209,519208,882206,696206,905206,425
Weighted Average Shares Outstanding (Diluted)242,258218,581219,885219,886215,261206,696206,905206,425

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About BCRX

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) is a stock listed on the Nasdaq Stock Market under the ticker symbol BCRX. It last traded at $7.69 (Nov 6, 2026, 4:00 PM ET), up 0.8% on the day. That gives BioCryst Pharmaceuticals a market capitalisation of $2.0B.

Over the past 52 weeks BCRX has traded between $6.23 and $11.22.

For the quarter ended Mar 31, 2026 it reported a net loss of $721.8M.

Last 4 quarters
Quarter endedRevenueNet income
Mar 31, 2026—-$721.8M
Dec 31, 2025—$245.8M
Sep 30, 2025—$12.9M
Jun 30, 2025—$5.1M

From BioCryst Pharmaceuticals’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…